One of the major challenges faced by the players in this market, especially CMOs that offer HPAPI manufacturing services, is the continual evolution of industry standards, technologies, and regulations.
Owing to their target release characteristics, HPAPIs find major applications in target therapies for cancer. Globally, there is a significant growth in the incidence of cancer. Diseases like musculoskeletal diseases, glaucoma, and specifically cancer have a significant impact on the health status of people worldwide, with comparatively higher growth rates in developing countries.
The 6th Annual MarketsandMarkets High Potent Medicines Virtual Conference to be held on 11-12 November 2021. This conference would address the challenges in continual evolution of industry standards, technologies, and regulations. Leading experts from the industry will discuss the strategies for both in-house manufacturing and outsourcing by presenting expert keynote presentations, live case studies and breakthrough panel discussions.
EHS Director, BSP Pharmaceuticals, Italy
Sales Director, FPS
Head, Product Stewardship and Health, Takeda, Switzerland
President, CEO, Affygility Soultions, USA
Senior Occupational Toxicologist, SafeBridge
Quality Assurance Manager, Vanessa Research
Consultant , Scale Up Solutions, USA
Manager Industrial Hygiene and Toxicology , Pharmascience, Canada
Principal Scientist, Toxicology , Boehringer Ingelheim, Germany
